Discovery IQ
1/3 of the scan time

Discovery IQ
1/3 of the scan time

Brain Ultra low dose CT using Q.AC technology

Patient 41 years old with parkinsonian syndrome submitted to PET/CT for exclusion of multiple system atrophy or other atypical parkinsonism.
Read more

Whole body low dose CT technique using Q.AC technology

Follow up PET/CT exam for head and neck malignancy restaging
Read more

Whole-body CT using ASIR* and Q.AC technologies for localization and attenuation correction purposes

Patient with progressive metastases of a neuroendocrine tumor confirmed by biopsy of the liver metastases (Cancer with unknown
Primary proliferation rate : MIB1Index 10%). Submitted to PET/CT for staging.
Read more